Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ly-Mee Yu

M.Sc., DPhil

Associate Professor and Deputy Director Academic (Primary Care Clinical Trials Unit)

  • Lead Trial Statistician

I joined the Department in 2013 after previously working at the Centre for Statistics in Medicine where I led a team of statisticians, collaborating on a variety of clinical studies (predominately randomised controlled trials) and supported numerous funding applications (e.g. NIHR, FP7, MRC, and Wellcome Trust).  I have over 27 years of experience as a medical statistician and specifically in clinical trials for the past 15 years.  I have worked in a wide range of clinical areas, including but not limited to, renal disease, behavioural medicine, vaccinology, cardiovascular medicine, infectious disease, surgery, allied health, mental health, neurosciences, respiratory, and orthopaedics.  I have published over 170 articles in peer-reviewed journals such as the Lancet, JAMA and the BMJ. 

I have currently the Deputy Director of the Primary Care Clinical Trials Unit (CTU) and lead a team of statisticians within the CTU.  I am also a senior adviser for the NIHR Research and Design Services (South Central), panel member of the NIHR Research for Patient Benefit funding programme, and member of the Oxford Tropical Research Ethnics Committee. I was a member of the NIHR Health Technology Assessment (HTA) Efficient Studies Board in 2016, and the Definitive Interventions and Feasibility Awards (HRB Ireland) in 2017 and 2018.  I am also a chair/member of data and safety monitoring committee, and the trial steering committee of several national and international trials.

My research interests include, platform trials, missing data, covariate adjustment in clinical trials, systematic review of reporting of clinical trials and prediction models.